Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals had revenue of $10.19B in the twelve months ending March 31, 2024, with 10.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.69B with 13.30% year-over-year growth. In the year 2023, Vertex Pharmaceuticals had annual revenue of $9.87B with 10.51% growth.

• Revenue (ttm): $10.19B
• Revenue Growth: +10.61%
• P/S Ratio: 12.00
• Revenue / Employee: $1,886,111
• Employees: 5,400
• Market Cap: 122.26B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.87B	938.50M	10.51%
Dec 31, 2022	8.93B	1.36B	17.91%
Dec 31, 2021	7.57B	1.37B	22.06%
Dec 31, 2020	6.21B	2.04B	49.08%
Dec 31, 2019	4.16B	1.12B	36.59%
Dec 31, 2018	3.05B	558.95M	22.46%
Dec 31, 2017	2.49B	786.48M	46.20%
Dec 31, 2016	1.70B	669.84M	64.89%
Dec 31, 2015	1.03B	451.92M	77.86%
Dec 31, 2014	580.42M	-631.56M	-52.11%
Dec 31, 2013	1.21B	-315.07M	-20.63%
Dec 31, 2012	1.53B	116.42M	8.25%
Dec 31, 2011	1.41B	1.27B	883.91%
Dec 31, 2010	143.37M	41.48M	40.71%
Dec 31, 2009	101.89M	-73.62M	-41.94%
Dec 31, 2008	175.50M	-23.51M	-11.81%
Dec 31, 2007	199.01M	-17.34M	-8.02%
Dec 31, 2006	216.36M	55.47M	34.47%
Dec 31, 2005	160.89M	58.17M	56.63%
Dec 31, 2004	102.72M	33.58M	48.56%
Dec 31, 2003	69.14M	-25.63M	-27.04%
Dec 31, 2002	94.77M	9.47M	11.11%
Dec 31, 2001	85.30M	-67.99M	-44.35%
Dec 31, 2000	153.28M	44.40M	40.77%
Dec 31, 1999	108.89M	79.83M	274.76%
Dec 31, 1998	29.06M	-14.74M	-33.66%
Dec 31, 1997	43.80M	25.20M	135.50%
Dec 31, 1996	18.60M	-8.94M	-32.45%
Dec 31, 1995	27.53M	4.39M	18.96%
Dec 31, 1994	23.15M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.